Patent · US Revoked

Pentacyclic heterocycles

US11267821B2 · kind B2 · utility

0Cited by
4References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 3, 2020
Grant dateMar 8, 2022
Priority date
Expiry dateMar 3, 2040

Classification

  • Technology area (CPC —)General

Abstract

The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.